Cargando…
Precision oncology in urothelial cancer
Genomics-driven, precision medicine has been adopted in virtually every tumour type and underlies the significant advances in cancer management to date. The paradigm shift from the indiscriminate use of chemotherapeutics, to strategies that harness our mechanistic knowledge of cancer biology has led...
Autores principales: | Liow, Elizabeth, Tran, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059486/ https://www.ncbi.nlm.nih.gov/pubmed/32132102 http://dx.doi.org/10.1136/esmoopen-2019-000616 |
Ejemplares similares
-
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
por: Clinton, Timothy N., et al.
Publicado: (2022) -
Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
por: Sheu, Zai-Lin, et al.
Publicado: (2022) -
Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II
por: Yang, Tsung-Mu, et al.
Publicado: (2023) -
The Future of Precision Oncology
por: Rulten, Stuart L., et al.
Publicado: (2023) -
Precision Medicine to Treat Urothelial Carcinoma—The Way Forward
por: Luceno, Carvy Floyd, et al.
Publicado: (2023)